Mochida Pharmaceutical Co., Ltd.

TSE:4534.T

3260 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 25,40724,66728,74224,72924,74721,86728,19425,50827,69225,36530,80526,64727,36223,12228,25024,24527,37822,71227,58325,02126,48522,02230,39727,43529,79823,03429,12725,57729,01124,31426,60421,91824,51720,11626,79822,71622,64419,97524,86321,98420,43922,25526,36622,96722,36520,59225,00122,28521,35218,33025,34923,48519,03218,73221,56719,50819,51716,95122,34819,80819,43716,98220,90418,638
Cost of Revenue 12,45112,94013,91412,41911,54210,92512,45012,33712,43412,64112,90612,67312,40611,27012,44211,51212,97911,61313,35412,56412,35110,81515,73914,82414,09912,74813,84513,20613,38312,60810,1448,7869,5058,23810,8579,3188,8607,7719,9728,4107,7608,0789,6928,4428,1527,6889,2398,1317,7396,8588,3167,6217,0467,0748,3947,5317,3726,4608,2427,3587,0366,4627,8496,978
Gross Profit 12,95611,72714,82812,31013,20510,94215,74413,17115,25812,72417,89913,97414,95611,85215,80812,73314,39911,09914,22912,45714,13411,20714,65812,61115,69910,28615,28212,37115,62811,70616,46013,13215,01211,87815,94113,39813,78412,20414,89113,57412,67914,17716,67414,52514,21312,90415,76214,15413,61311,47217,03315,86411,98611,65813,17311,97712,14510,49114,10612,45012,40110,52013,05511,660
Gross Profit Ratio 0.510.4750.5160.4980.5340.50.5580.5160.5510.5020.5810.5240.5470.5130.560.5250.5260.4890.5160.4980.5340.5090.4820.460.5270.4470.5250.4840.5390.4810.6190.5990.6120.590.5950.590.6090.6110.5990.6170.620.6370.6320.6320.6360.6270.630.6350.6380.6260.6720.6750.630.6220.6110.6140.6220.6190.6310.6290.6380.6190.6250.626
Reseach & Development Expenses 03,5274,1722,3502,5054,5522,2833,7432,70512,2952,5993,0693,4392,79800011,88400013,00300011,91200015,22600013,45400011,77700011,96100012,519000000000000000000
General & Administrative Expenses 011,71612,98810,87410,68912,79110,66700-3,3340003,896000-3,206000-3,312000-3,603000-2,650000-2,836000-2,770000-4,871000-3,218000000000000000000
Selling & Marketing Expenses 0-3,527-4,172-2,3500-4,552-2,283004,2510004,3390004,4440004,4120004,6820004,4550004,5870004,9910005,4120005,282000000000000000000
SG&A 10,7668,1898,8168,52410,6898,2398,3848,41410,99291710,98611,0258,3338,23511,85310,0989,8041,23812,07610,7769,6141,10010,99411,1579,5301,07911,16210,2369,6731,80510,60310,01810,8941,75111,02210,6529,4682,22110,11911,76510,21854110,76710,69510,1052,06412,19810,0680000000000000000
Other Expenses 03433530614192447624639102431301631324415283251434362611252911,70311,022341837238362821303262-1872214944174501353618241258553888345176117-12
Operating Expenses 10,76611,71612,98810,87410,68912,79110,66712,15710,99211,37810,98611,02511,77211,03311,85310,0989,80410,64612,07610,7769,61411,90310,99411,1579,53010,83311,16210,2369,67313,42110,60310,01810,89411,70311,02210,6529,4689,55610,11911,76510,21811,42010,76710,69510,10510,45512,19810,0689,69310,10010,8479,59910,88011,1698,8088,8268,6409,1019,6578,3248,4188,9448,2488,404
Operating Income 2,190111,8391,4372,515-1,8495,0771,0144,2651,3476,9142,9483,1838193,9552,6354,5944542,1531,6814,519-6963,6641,4556,167-5474,1202,1355,954-1,7145,8563,1154,1171744,9192,7464,3152,6484,7711,8102,4602,7575,9063,8304,1072,4483,5634,0863,9201,3726,1866,2651,1064894,3653,1513,5051,3904,4494,1263,9831,5764,8073,256
Operating Income Ratio 0.08600.0640.0580.102-0.0850.180.040.1540.0530.2240.1110.1160.0350.140.1090.1680.020.0780.0670.171-0.0320.1210.0530.207-0.0240.1410.0830.205-0.070.220.1420.1680.0090.1840.1210.1910.1330.1920.0820.120.1240.2240.1670.1840.1190.1430.1830.1840.0750.2440.2670.0580.0260.2020.1620.180.0820.1990.2080.2050.0930.230.175
Total Other Income Expenses Net 1741061554056286118-16148-5125228632-181-45-44167-2,80310415150-785152131,671-130212141-10-6252004221-379258-69471-29103276449-93564-33-13314541185545-581-3,177171-42474376241,1422931179950
Income Before Tax 2,3641171,9941,4772,572-1,5635,1959984,4148346,9642,9773,8166373,9102,5914,762-2,3492,2561,6964,670-1,4813,8171,4677,839-5494,4232,1466,096-1,7255,8513,1404,3172174,9392,3674,5741,9554,8421,7802,5642,7845,9703,8803,1722,5133,5303,9534,0651,4136,3716,810525-2,6884,5362,7273,5791,7664,4735,2684,2761,6934,9063,306
Income Before Tax Ratio 0.0930.0050.0690.060.104-0.0710.1840.0390.1590.0330.2260.1120.1390.0280.1380.1070.174-0.1030.0820.0680.176-0.0670.1260.0530.263-0.0240.1520.0840.21-0.0710.220.1430.1760.0110.1840.1040.2020.0980.1950.0810.1250.1250.2260.1690.1420.1220.1410.1770.190.0770.2510.290.028-0.1430.210.140.1830.1040.20.2660.220.10.2350.177
Income Tax Expense 80914389326884-1301,0362301,2594451,7017141,1624579135471,395-5694704091,365-679053731,996-3021,0755421,777-4551,6188531,0414641,3577511,3749051,4456046431,3951,8701,4161,2328461,1981,4741,3917202,6932,377253-1,3301,7291,0021,4196251,6621,9311,6946171,859673
Net Income 1,5541031,6061,1501,688-1,4324,1587683,1553895,2642,2632,6531802,9962,0443,367-1,7801,7861,2873,305-1,4142,9131,0935,843-2473,3481,6044,318-1,2694,2332,2873,275-2483,5831,6163,1991,0513,3961,1771,9201,3884,1002,4641,9401,6672,3332,4782,6746933,6784,433272-1,3582,8061,7252,1591,1402,8103,3362,5821,0773,0462,633
Net Income Ratio 0.0610.0040.0560.0470.068-0.0650.1470.030.1140.0150.1710.0850.0970.0080.1060.0840.123-0.0780.0650.0510.125-0.0640.0960.040.196-0.0110.1150.0630.149-0.0520.1590.1040.134-0.0120.1340.0710.1410.0530.1370.0540.0940.0620.1560.1070.0870.0810.0930.1110.1250.0380.1450.1890.014-0.0720.130.0880.1110.0670.1260.1680.1330.0630.1460.141
EPS 43.833.3245.1632.2846.23-39.1112.3820.5283.9810.31137.8259.1269.334.778.2952.7486.89-45.9346.0932.8184.25-36.0474.2627.53147.19-6.2284.3340.4108.77-31.96106.6157.5982.48-6.2590.2340.6980.5626.4685.5129.347.8334.56102.0859.9447.240.5556.7559.7964.5316.7288.74102.776.33-31.4862.8538.6448.3825.5361.5173.0256.5223.5758.0450.17
EPS Diluted 43.833.3245.1632.2846.23-39.1112.3820.5283.9810.31137.8259.1269.334.778.2952.7486.89-45.9346.0932.8184.25-36.0474.2627.53147.19-6.2284.3340.4108.77-31.96106.6157.5982.48-6.2590.2340.6980.5626.4685.5129.347.8334.56102.0859.9447.240.5556.7559.7964.5316.7288.74102.776.33-31.4862.8538.6448.3825.5361.5173.0256.5223.5758.0450.17
EBITDA 2,8957612,0051,4622,592-1,4685,0781,0454,2661,8637,0182,9832,7331,0144,0872,6944,5683,3042,1581,7124,516-6533,8271,4706,286-4894,2322,1706,098-1,6795,8743,1424,3202304,9682,7854,4222,7074,8621,7912,5702,7965,9773,8634,1912,4973,5404,1144,0741,4256,3666,3221,2441,3445,3143,8634,4022,7355,3034,8114,9342,5135,4733,207
EBITDA Ratio 0.1140.0310.070.0590.105-0.0670.180.0410.1540.0730.2280.1120.10.0440.1450.1110.1670.1450.0780.0680.171-0.030.1260.0540.211-0.0210.1450.0850.21-0.0690.2210.1430.1760.0110.1850.1230.1950.1360.1960.0810.1260.1260.2270.1680.1870.1210.1420.1850.1910.0780.2510.2690.0650.0720.2460.1980.2260.1610.2370.2430.2540.1480.2620.172